top of page
The Coalition to
Protect Patient Choice
A Project
of the
Law Offices
of David Balto
Competitive healthcare is healthcare with choices
Advocacy on consumer healthcare competition issues aimed at lowering prescription drug costs
Archive
Public Citizen's comments to FTC regarding AbbVie/Allergan merger
The FTC should more fully consider the range of harms to consumers, and require stronger conditions to prevent anticompetitive conduct, June 11th 2020
Letter to GAO
An assessment of the prevalence of rebate traps in pharmaceutical markets and their effects on pharmaceutical pricing, competition, and innovation. June 10, 2020
Letter to GAO
Proposal asking the Government Accountability Office (GAO) to conduct an assessment of the prevalence of rebate traps in pharmaceutical markets and their effects on pharmaceutical pricing, competition, and innovation. June 10, 2020
Letter from 9 U.S senators opposing the AbbVie allergen merger and need to investigate rebate walls
September 17, 2019
bottom of page